Viora Promotes Dr. Inna Belenky (Ph.D) To VP Marketing & Clinical Affairs

Thursday, February 28, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Viora, a leading medical aesthetics solutions provider, today announces the promotion of Dr. Inna Belenky (Ph.D) to VP Marketing & Clinical Affairs.

NEW YORK, Feb. 28, 2019 /PRNewswire-PRWeb/ -- Dr. Belenky will be responsible for leading Viora's "go to market strategy"

and derivative activities including product, marketing communication, and clinical development.

"Inna has demonstrated uncompromising dedication and commitment to Viora and has contributed immensely towards the company's growth and achievements over the last 8.5 years," said Eliran Almog, CEO, Viora Ltd. "Inna's academic background, clinical experience together with abilities as a strong leader and positive role model for the company, will continue to drive Viora's success around the world."

"I'm excited about the opportunity to continue expanding Viora's marketing & clinical affairs to the international presence while implementing Viora's revenue driven goals into our marketing, clinical and product performance," said Dr. Inna Belenky.

Dr. Belenky's former positions with Viora included Clinical Director and Scientific Expert.

About Viora Viora is a market-leading aesthetic solutions provider for skincare applications for patients seeking the most advanced developments for the most requested treatments: rejuvenation, resurfacing, body & facial contouring, skin tightening, cellulite reduction, acne control, lightening, hydration, hair removal, exfoliation and more. Viora's expertise in developing solutions and technology for these applications ensures greater physician and client satisfaction. Viora's extensive knowledge and experience has been forged from its expansive connections to the aesthetic community. This has allowed Viora to create the most sought after solutions and achieve the most effective results. For more information, visit http://www.vioramed.com

 

SOURCE Viora



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store